Edition:
United Kingdom

West Pharmaceutical Services Inc (WST.N)

WST.N on New York Stock Exchange

106.02USD
7 Dec 2018
Change (% chg)

$-2.48 (-2.29%)
Prev Close
$108.50
Open
$107.88
Day's High
$109.10
Day's Low
$105.29
Volume
85,888
Avg. Vol
86,363
52-wk High
$125.04
52-wk Low
$82.79

Latest Key Developments (Source: Significant Developments)

West Pharmaceutical Services Reports Q2 Earnings Per Share Of $0.75
Thursday, 26 Jul 2018 

July 26 (Reuters) - West Pharmaceutical Services Inc ::WEST ANNOUNCES SECOND-QUARTER 2018 RESULTS.REAFFIRMS FY 2018 ADJUSTED EARNINGS PER SHARE VIEW $2.80 TO $2.90.Q2 EARNINGS PER SHARE $0.75.SEES FY 2018 SALES $1.72 BILLION TO $1.73 BILLION.Q2 SALES $447.5 MILLION VERSUS I/B/E/S VIEW $424.5 MILLION.Q2 ADJUSTED EARNINGS PER SHARE $0.70.Q2 EARNINGS PER SHARE VIEW $0.67 -- THOMSON REUTERS I/B/E/S.REAFFIRMED FINANCIAL GUIDANCE FOR FULL-YEAR 2018.REVISING ITS 2018 CAPITAL SPENDING GUIDANCE TO BE IN A RANGE OF BETWEEN $120 MILLION AND $130 MILLION.ASSUMES AN EXPECTED TRANSLATION EXCHANGE RATE OF $1.15 PER EURO FOR SECOND HALF OF 2018.  Full Article

West reports Q3 earnings per share of $0.67
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - West Pharmaceutical Services Inc :West announces third-quarter 2017 results.Sees fy 2017 adjusted earnings per share $2.74 to $2.79.Q3 earnings per share $0.67.Q3 sales $398.2 million versus I/B/E/S view $385.9 million.Q3 earnings per share view $0.53 -- Thomson Reuters I/B/E/S.Sees FY 2017 sales $1.595 billion to $1.605 billion.Says ‍hurricanes in Puerto Rico had a negative impact on third-quarter 2017 sales of approximately $2 million​.West Pharmaceutical Services Inc says ‍reaffirmed long-term financial targets​.West Pharmaceutical Services Inc - ‍company estimates its 2017 capital spending to be approximately $150 million​.West Pharmaceutical Services Inc - ‍expects 2018 constant-currency, organic sales growth to be in range of 6% to 8%​.FY2017 earnings per share view $2.67, revenue view $1.59 billion -- Thomson Reuters I/B/E/S.FY2018 revenue view $1.72 billion -- Thomson Reuters I/B/E/S.West Pharmaceutical - at current low levels operations at Puerto Rico , estimate Q4 2017 sales to be adversely impacted by approximately $5 million​.  Full Article